Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

StealthGas (NASDAQ:GASS) reported higher first-quarter revenue and continued to emphasize its debt-free balance sheet, growing cash position and charter coverage during its first-quarter 2026 earnings call. Chairman Michael Jolliffe said revenue rose to $42.8 million in the quarter, up 2% from $42

MarketBeat

NVIDIA's New Power Play: Why Fluence Is Surging

Fluence Energy's validation by Siemens and NVIDIA positions it as a key supplier of power infrastructure to support the global AI build-out.

MarketBeat

Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge

Broadcom just saw a big run-up going into its latest earnings report and a crash following it. Here's what caused shares to slip.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Saputo Q4 Earnings Call Highlights

Saputo (TSE:SAP) executives said the dairy processor ended fiscal 2026 with stronger margins, improved cash generation and a more focused portfolio, even as lower U.S. dairy commodity pricing weighed on reported revenue in the fourth quarter. On the company’s fourth-quarter earnings call, President

MarketBeat

ABM Industries Q2 Earnings Call Highlights

ABM Industries (NYSE:ABM) reported stronger second-quarter fiscal 2026 revenue growth and record first-half new sales bookings, while management maintained its full-year adjusted earnings outlook and said it expects a stronger margin performance in the second half of the year. President and Chief E

MarketBeat

G-III Apparel Group Q1 Earnings Call Highlights

G-III Apparel Group (NASDAQ:GIII) reported first-quarter fiscal 2027 results that exceeded its own expectations, as stronger gross margins and growth in its go-forward brand portfolio helped offset the planned loss of revenue tied to PVH brands. Chairman and Chief Executive Officer Morris Goldfarb

MarketBeat

Five Below Down 12% Post Earnings—Is the Selloff Overdone?

Five Below fell more than 13% after Q1 2026 earnings beat estimates, as cautious second-half guidance and tariff uncertainty overshadowed strong revenue and EPS results.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Arrow Financial Highlights Profit Gains, Adirondack Bank Deal at Annual Meeting

Arrow Financial (NASDAQ:AROW) used its virtual annual meeting to highlight what executives described as a transformational 2025, including the first full year operating under the unified Arrow Bank brand, stronger profitability metrics and progress toward its planned acquisition of Adirondack Bank.

MarketBeat

Tuniu Q1 Earnings Call Highlights

Tuniu (NASDAQ:TOUR) reported higher first-quarter revenue and its fifth consecutive quarter of non-GAAP profitability, as management said China’s travel market continued to benefit from solid demand during the period, including support from the longest Chinese New Year holiday on record. Founder, C

MarketBeat

The Market Has Ollie’s Bargain Outlet Completely Wrong

Ollie's Bargain Outlet is executing strategy, growing, and widening margin but will it be enough to get the stock price action advancing?

MarketBeat

Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious

Macy's topped first-quarter expectations and raised its outlook, but Wall Street remains cautious despite signs the turnaround is gaining traction.

MarketBeat

NVIDIA Sends a Message With RTX Spark—This Is What It Says

NVIDIA is in control of AI, driving its evolution at all levels of the stack as it enters the PC market. RTX Spark is another game changer for tech.

MarketBeat

Buy the Dip? Broadcom's AI Moat Is Wider Than Ever

Broadcom secures massive custom silicon demand as hyperscalers pour unprecedented capital into artificial intelligence infrastructure across the globe.

MarketBeat

argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference

argenx (NASDAQ:ARGX) Chief Financial Officer Karl Gubitz told investors at the 46th Annual William Blair Growth Stock Conference that the biotechnology company remains focused on revenue growth, profitability and execution as it expands the VYVGART franchise and advances additional pipeline assets.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the Jefferies Global Healthcare Conference in New York. Payne described Arcturus as a “next generation messen

MarketBeat

Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference

Amgen (NASDAQ:AMGN) executives used a Jefferies investor conference appearance to emphasize the company’s first-quarter growth, its late-stage pipeline and its preparations for potential launches, including the obesity candidate MariTide. Peter Griffith, executive vice president and chief financial

MarketBeat

Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End

Alvotech (NASDAQ:ALVO) is at an “inflection point” after more than a decade of investment in its biosimilar platform, Founder and Executive Chairman Róbert Wessman said at the Jefferies Global Healthcare Conference in New York. Speaking with Jefferies analyst Marco Baruzzi, Wessman said Alvotech ha

MarketBeat

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure

Align Technology (NASDAQ:ALGN) CFO John Morici said the company continues to navigate a challenging but stable demand environment, with international markets and dental service organizations offsetting pressure in parts of North America. Speaking at the Jefferies Global Healthcare Conference in a f

MarketBeat

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment

Aldeyra Therapeutics (NASDAQ:ALDX) Chief Executive Todd Brady said the company expects near-term feedback from the U.S. Food and Drug Administration on its dry eye disease candidate reproxalap, following a third complete response letter tied to efficacy questions. Speaking at a Jefferies fireside c

MarketBeat

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near

Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a fireside chat at the Jefferies 2026 Global Healthcare Conference. Erik, Akebia’s chief financial offic

MarketBeat

Rubrik Q1 Earnings Call Highlights

Rubrik (NYSE:RBRK) reported what executives described as a record first quarter of fiscal 2027, exceeding its guided metrics and raising its full-year outlook as the cybersecurity company pointed to growing demand for cyber resilience in an AI-driven threat environment. Chief Executive Officer Bipu

MarketBeat

Planet Labs PBC Q1 Earnings Call Highlights

Planet Labs PBC (NYSE:PL) reported record first-quarter fiscal 2027 revenue and raised its full-year sales outlook, citing strong demand from defense and intelligence customers, international governments seeking sovereign space capabilities, and expanding use of its AI-enabled geospatial products.

MarketBeat

Guidewire Software Q3 Earnings Call Highlights

Guidewire Software (NYSE:GWRE) reported stronger-than-expected fiscal third-quarter revenue, profitability and cash flow, while management said demand for cloud migrations, pricing tools and AI-related products continued to build heading into the company’s seasonally important fourth quarter. Chief

MarketBeat

Samsara Q1 Earnings Call Highlights

Samsara (NYSE:IOT) reported a strong start to fiscal 2027, with executives highlighting accelerating growth among large customers, expanding adoption of emerging products and continued profitability during the company’s first-quarter earnings call. Chief Executive Officer and Co-founder Sanjit Bisw

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.